Hemant Surgical Industries Ltd 05 Nov 2026 12:00 AM
Hemant Surgical Industries to review financial results at a board meeting November 14,
Hemant Surgical Industries Limited will hold a board meeting on Saturday, November 14, 2026, to approve the unaudited financial results (standalone and consolidated) for the half year ended September 30, 2026, according to a regulatory filing with the BSE Limited. The trading window for the company`s securities is closed for designated persons from October 1, 2026, and will reopen 48 hours after the financial results are declared.
Hemant Surgical Industries Ltd 07 Oct 2026 12:00 AM
Hemant Surgical Industries confirms full share dematerialization, adhering to SEBI regulations,
Hemant Surgical Industries Limited informed the BSE Limited that Bigshare Services Pvt. Ltd. confirmed that Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 is not applicable to the company for the quarter ended September 30, 2026, as all shares are held in demat form and no requests for rematerialization were received.
Hemant Surgical Industries Ltd 28 Sep 2026 12:00 AM
Hemant Surgical Industries halts trading ahead of financial results declaration to BSE Limited,
Hemant Surgical Industries Limited will close its trading window for directors, promoters, designated employees, connected persons, and immediate relatives starting Thursday, October 01, 2026, in connection with the declaration of the company’s unaudited financial results for the half year ending September 30, 2026, according to a filing with the BSE Limited. The trading window will reopen 48 hours after the financial results are declared to the stock exchange.
Hemant Surgical Industries Ltd 29 Aug 2026 12:00 AM
Hemant Surgical Industries approves annual report, schedules meeting for September 29, 2026,
Hemant Surgical Industries Limited informed the BSE Limited that its Board of Directors approved the Directors’ Report and Management Discussion and Analysis Report for the financial year ended March 31, 2026, and decided to hold the 37th Annual General Meeting of its members on September 29, 2026, at 12:30 P.M. (IST) through video conferencing or other audio-visual means.
Hemant Surgical Industries Ltd 10 Jun 2026 12:00 AM
HSIL acquires majority stake in Lifesenz Cancer Research Labs,
Hemant Surgical Industries has completed the strategic acquisition of a majority stake (66.66%) in Lifesenz Cancer Research Labs (Lifesenz), a company focused on precision oncology and personalized cancer treatment solutions for an amount of Rs. 19.98 crore, making Lifesenz a subsidiary of the Company with effect from 01 June 2026.
Subscribe for our
newsletter
Open Account Now